Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer would result in equivalent surv...
Saved in:
| Main Authors: | Jaime D. Lewis, Anees B. Chagpar, Elizabeth A. Shaughnessy, Jacob Nurko, Kelly McMasters, Michael J. Edwards |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-11-01
|
| Series: | Опухоли женской репродуктивной системы |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action
by: Nayoung Kim, et al.
Published: (2025-04-01) -
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone
by: James N. Ingle, et al.
Published: (2025-03-01) -
Efficacy of clomiphene citrate and tamoxifen on pregnancy rates in idiopathic male subfertility: A systematic review and meta-analysis
by: Shadi Khashaba, et al.
Published: (2025-01-01) -
Analysis of advanced non-small cell lung cancer course during high dose antiestrogen therapy use in complex chemoradiotherapy treatment of patients
by: A. V. Kadzhoian
Published: (2014-12-01) -
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
by: Coralie Poulard, et al.
Published: (2023-07-01)